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Abstract
Signaling through the T cell antigen receptor (TCR) is important for the homeostasis of naı¨ve and memory CD4+ T cells. The
significance of TCR signaling in regulatory T (Treg) cells has not been systematically addressed. Using an Ox40-cre allele that
is prominently expressed in Treg cells, and a conditional null allele of the gene encoding p56Lck, we have examined the
importance of TCR signaling in Treg cells. Inactivation of p56Lck resulted in abnormal Treg homeostasis characterized by
impaired turnover, preferential redistribution to the lymph nodes, loss of suppressive function, and striking changes in gene
expression. Abnormal Treg cell homeostasis and function did not reflect the involvement of p56Lck in CD4 function because
these effects were not observed when CD4 expression was inactivated by Ox40-cre.The results make clear multiple aspects
of Treg cell homeostasis and phenotype that are dependent on a sustained capacity to signal through the TCR.
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Introduction
Regulatory T cells (Treg cells) are defined by expression of the
Forkhead transcription factor FoxP3 and by potent immunosup-
pressive capability [1–4]. These cells develop in the thymus
through a CD25hiCD4+CD82 intermediate in a process that
depends on the cc cytokines IL-2, -7 or -15 [5–7]. Treg cells can
also be generated extrathymically in a TGFb-dependent fashion
from conventional naı¨ve T cells [8–14] and such induced Treg
cells can be of significance for control of destructive immune
responses [15]. The crucial importance of Treg cells for preventing
autoimmunity is made clear by the systemic disease that develops
when they are defective or ablated [2,3,16,17].
T cells show variable dependency on TCR signaling for
homeostasis as a function of their lineage and differentiation state.
Naı¨ve T cells are dependent on tonic TCR signaling for survival,
but they lose this dependency when they become memory cells
[18–21]. There have, however, been conflicting observations
about this [22,23]. While it has not been systematically addressed,
there are indications that like memory CD8+ T cells, Treg cell
homeostasis is minimally influenced by TCR signaling [24].
In this paper we have examined the importance of TCR
signaling in Treg cell homeostasis using a novel mouse strain that
features conditional loss of TCR signaling due to inactivation of
p56Lck function. We find that the deficiency substantially changes
the gene expression profile and the turnover of Treg cells, while
also causing them to redistribute from the spleen and the tissues to
the lymph nodes. The results reveal important roles for TCR
signaling in maintaining the Treg phenotype and in governing
Treg cell migration.
Results
Expression of Ox40-cre in Regulatory T Cells
Ox40-cre is an allele of the Ox40 gene that expresses the Cre
recombinase in place of OX40 [25]. To determine which cells
undergo Cre recombination in Ox40-cre mice, we crossed them to
mice carrying a Cre-activated ROSA26-YFP reporter allele [26].
98% of peripheral T cells that had undergone recombination and
become YFP+ in such mice were CD4+ (Figure 1A), and among
these one-third to one-half were FoxP3+ depending on age at the
time of analysis. Strikingly, approximately 90% of lymph node or
spleen CD25+ T cells were YFP+ indicating that Ox40-cre is highly
efficient at inducing recombination in the regulatory lineage
(Figure 1B).
Less than 1% of thymocytes in Ox40-cre/YFP mice had
undergone recombination, and the majority of these were
CD4+CD82 single-positive cells (Figure 1A). As in the periphery,
there was a high frequency of FoxP3+ cells in the affected
population. Thymic precursors of Treg cells can be discriminated
by a CD25hi CD4+CD82 phenotype [6], and 65–70% of these
were YFP+. Double-negative and double-positive thymocytes were
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negative for YFP expression (Figure 1C). Thus, Ox40-cre activity
was evident in the thymus at the stage at which cells induce FoxP3
expression and are committed to the Treg lineage.
Disruption of TCR signaling in Regulatory T cells by Ox40-
cre
To examine the importance of TCR signaling in the
homeostasis and function of Treg cells, we crossed Ox40-cre mice
to mice carrying a conditional null (loxP-modified) allele of the Lck
gene (Benjamin et al., in preparation). Cre recombination
incapacitates this allele such that it can no longer express a
functional p56Lck protein. Although loss of p56Lck greatly impairs
TCR signaling [27], the related Src-family kinase p59Fyn can
partially compensate for its absence in some settings, most notably
at the pre-TCR-dependent stage of development in the thymus
[28,29]. For this reason, we combined the Ox40-cre and
conditional null alleles of Lck (Lckc) with a null allele of the Fyn
gene so that we could deprive cells of both kinases when they
expressed the Ox40 gene.
Mice with four types of T cell genotypes were examined in our
experiments: wild-type (Control), Fyn-deficient (Fyn2/2 referred to
as Fyn), Lck-deficient (Lckc/2;Ox40-cre referred to as Lck), and
Lck,Fyn-deficient (Fyn2/2;Lckc/2;Ox40-cre referred to as Lck/Fyn).
The Ox40-cre allele was always kept heterozygous so that T cells
would retain the capacity to express near-normal levels of cell
surface OX40 from one copy of the wild-type Ox40 allele [30].
Ox40-cre heterozygous mice (lacking conditional null alleles) were
free of detectable abnormal T cell phenotypes (data not shown).
Figure 1. Activity of Ox40-cre in regulatory T cells. A. Thymic and lymph node expression of YFP in Ox40-cre/YFP mice (i.e., Ox40-cre mice
carrying a ROSA26-loxP-STOP-loxP-YFP allele). The contour plots show that YFP expression is predominantly found on CD4+CD82 cells in both tissues
(as determined by flow cytometry). FoxP3+ cells are enriched 30–40 fold in the YFP+CD4+CD82population compared to YFP2 cells. B. Penetrance of
Ox40-cre recombination in CD4+CD82CD25+ cells in the lymph nodes and thymus. The histograms show the frequency of YFP expression in
regulatory phenotype cells in both tissues of Ox40-cre/YFP mice. C. Developmental stage-specific activity of Ox40-cre in the thymus. The plots show
YFP expression is predominantly found in cells that are CD4+CD82 and is barely detectable at the CD4+CD8+ stage.
doi:10.1371/journal.pone.0006580.g001
Loss of p56Lck in Treg Cells
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Ox40-cre-dependent loss of p56Lck expression could be visualized
by intracellular flow cytometry using the 1F6 p56Lck-specific
monoclonal antibody (Figure 2). Whereas CD4+ T cells from
control or Fyn mice showed equivalent staining with this antibody,
there was selective loss of immunoreactivity in CD4+ T cells from
Lck or Lck/Fyn mice (Figure 2A). Inactivation of p56Lck could be
detected in a small fraction of phenotypically naı¨ve CD4+ T cells, a
larger fraction of memory-phenotype CD4+ T cells, and the
majority of FoxP3+ T cells (Figure 2B). These observations were
largely consistent with the expected pattern of expression of Ox40-
cre based on the analysis of mice carrying the YFP reporter
(Figure 1 and data not shown). We noted, however, that the
frequency of Treg cells that retained wild-type p56Lck was two-to-
four-fold higher than the YFP analysis predicted in the lymph
nodes and spleen respectively (Figure 2C). This disparity raised the
possibility that Treg cell homeostasis was disturbed by inactivation
of p56Lck.
Abnormal T cell homeostasis caused by inactivation of
the Lck gene by Ox40-cre
Regulatory T cells were about two-fold reduced in number in
the thymuses and spleens of Lck and Lck/Fyn mice compared to
control or Fyn mice (Figure 3AB). By contrast their numbers were
increased in the lymph nodes of the two Lck mutants (Figure 3B)
but this was associated with little, if any, change in their
representation as a fraction of the CD4+ population (Figure 3A).
Instead, the apparent accumulation of p56Lck-deficient Treg cells
in the lymph nodes was a consequence of mild lymphadenopathy
in the mutant mice and an associated increase in T cell numbers
(Figure 3B).
p56Lck deficiency has been found previously to impair
proliferation of T cells in lymphopenic recipients [31]. To test
whether this was also true of Treg cells and might account for
some of the homeostatic defects just described, we purified CD25+
and CD252 cells from mice of the four genotypes and transferred
them intravenously into T cell-deficient recipients. Wild-type and
p59Fyn-deficient CD25+ cells demonstrated characteristic prolifer-
ation in the recipient mice, whereas the Lck and Lck/Fyn T cells
failed to make this response (Figure S1A). p56Lck-deficient CD252
cells were capable of some expansion but they failed to go through
the same number of divisions as cells that expressed p56Lck.
To look further at Treg cell homeostasis following loss of p56Lck,
we labeled dividing cells in vivo by treating the mice with BrdU for
two weeks. We then monitored the decay of BrdU+ cells (due to
division or death) over time. BrdU labeling was much more
prominent in cells that retained p56Lck than in cells in the same
mice (or in control mice) that had lost it (Figure S1B). Moreover,
although the control cells showed marked loss of the BrdU label
during the analysis period, the frequency of labeled p56Lck-
deficient cells was considerably more stable. Thus, loss of p56Lck
expression impaired Treg cell turnover without imparting a major
effect on survival. Consistent with these data, DAPI labeling
experiments revealed a much-reduced frequency of mitoses in
p56Lck-deficient compared to p56Lck-expressing Treg cells (Figure
S1C).
TCR Signaling is Not Required for Retention of FoxP3
Expression, but is Required for Regulatory T cell Function
Loss of p56Lck did not abrogate FoxP3 expression as detected by
FACS (Figure 3A) or by real-time PCR (Figure 4A) although by
both techniques there was a reproducible slight decrease in the
mean FoxP3 expression level. Some diminution in FoxP3 levels
might be expected because acute activation increases FoxP3
protein expression [2], and such activation would not occur in the
mutant Treg cells. The data nonetheless indicated that retention of
basal FoxP3 expression is a stable aspect of the Treg lineage and
does not depend upon persistent TCR signaling.
To test whether TCR signaling was essential for suppression
mediated by Treg cells, we sorted CD25+CD4+ T cells from the
four genotypes and mixed them at varying ratios with
CD252CD4+ T cells before stimulating them in vitro with anti-
CD3 in the presence of splenic accessory cells. Whereas wild-type
and p59Fyn-deficient CD25+ T cells had equivalent capacity to
suppress proliferation, the Lck and Lck/Fyn CD25+ T cells were
incapable of suppression (Figure 4B). Thus, TCR signaling via
p56Lck is essential for suppression by Treg cells.
The CD4 molecule enhances TCR signaling in part through its
capacity to interact with p56Lck [32]. To determine whether, like
p56Lck, CD4 is also important for Treg cell homeostasis and
function, we generated mice in which the Cd4 gene was inactivated
by Ox40-cre through use of a conditional null Cd4 allele [33]. These
mice had normal frequencies of Treg cells in their lymphoid
organs even though the majority of them lacked CD4 expression
(data not shown). Consistent with the involvement of CD4 in T
cell activation, its loss correlated with a reduction in the frequency
of cells expressing markers of acute activation such as CD69 and
CD44 (Figure S2). Despite this, however, the CD4-deficient Treg
cells were nonetheless capable of efficiently suppressing T cell
responses in vitro (data not shown). These data make clear that
disturbed Treg cell homeostasis and function caused by loss of
p56Lck reflects the primary involvement of this kinase in the TCR
signaling pathway, and by contrast Treg cells show little
dependency on CD4 for homeostasis or in vitro suppression.
Changes in regulatory T cell gene expression caused by
absence of p56Lck
Although p56Lck-deficient Treg cells remained positive for
FoxP3 and CD25 expression, we considered it likely that the loss
of TCR signaling would incur changes in gene expression. This
might be predicted if the TCR signal is important for maintaining
the differentiated state of the cells, and would also follow from
prior data showing that tonic TCR signaling regulates expression
of numerous genes in T cells [34]. By flow cytometry, we noted
multiple changes in the expression of molecules known to be
regulated by TCR signaling such as GITR, CD69, CD44, CD62L
and CTLA4 (Figure 5). CD4 expression was also reduced,
consistent with the known involvement of p56Lck in reducing the
rate of CD4 endocytosis [35,36].
To look more exhaustively for changes in gene expression, we
used microarrays to compare Treg cells that did or did not express
p56Lck. To identify p56Lck-dependent changes in gene expression
that were unique to Treg cells, we also made the same comparison
for CD4+CD252CD44hi cells (i.e., memory/effector T cells).
We identified a collection of genes that changed significantly in
their expression in regulatory and/or memory T cells as a
consequence of p56Lck deficiency (Figure 6A and B, Table S1).
20% of these genes increased in expression in both types of p56Lck-
deficient T cells (Figure 6B top right quadrant). An even smaller
proportion (13%) registered an increase in one or the other, but
not both populations (Figure 6B). In marked contrast, the
dominant consequence of the deficiency (in 67% of cases) was a
reduction in expression in both types of T cell (Figure 6B bottom
left quadrant). In general, therefore, the data showed that p56Lck,
and thus the TCR signal, is more important for maintaining gene
expression than for repressing it.
Among the genes that emerged as differentially expressed in the
presence versus the absence of p56Lck, there were many whose
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Figure 2. Ox40-cre-mediated inactivation of p56Lck in T cells. A. Selective inactivation of p56Lck in CD4+ T cells in lymph nodes of Ox40-cremice
carrying a conditional null allele of the Lck gene. The histograms show intracellular p56Lck detected with the 1F6 monoclonal antibody in B cells, CD4+
and CD8+ T cells in mice of the indicated genotypes. B. Intracellular p56Lck (as in A.) in T cells of the indicated phenotypes (regulatory, memory and
naı¨ve) from Lck/Fyn mice. C. Increased frequency of Treg cells that had not undergone Ox40-cre-mediated recombination in mice carrying the
conditional null Lck allele compared to mice carrying the ROSA26-YFP allele. The graph shows the frequencies of YFP2 or p56Lck-positive (1F6+) CD25+
Treg cells in individual mice of the indicated genotypes.
doi:10.1371/journal.pone.0006580.g002
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Figure 3. p56Lck-deficient regulatory T cells. A. Flow cytometry data showing frequencies of Treg cells in mice of the indicated genotypes in the
thymus, spleen and lymph nodes. B. Frequencies of thymic and peripheral Treg cells in individual mice of the indicated genotypes (bottom panel).
The top panel shows total cell recovery from each of the tissues in the same mice. Asterisks identify differences (compared to control) that were
statistically significant by ANOVA (p,0.05).
doi:10.1371/journal.pone.0006580.g003
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regulation had previously been linked to the TCR stimulus in
other studies (e.g., genes encoding Egr-1, Egr-2, Egr-3, CD83, c-
Myb, CD200, CD44, ALCAM and Stra13). Consistent with this,
the differentially expressed collection from both memory and Treg
cells was significantly enriched for genes with gene ontology (GO)
term annotation related to lymphocyte activation (Table S2).
Other enriched categories for both populations included immune
system development, cell differentiation, immune response,
signaling and apoptosis. The majority of the significantly enriched
terms were associated with genes that were downregulated
following inactivation of p56Lck and thus were located in the
lower left quadrant of the plot in Figure 6B (q3 in Table S3).
Several studies have identified genes that are differentially
expressed in Treg cells compared to conventional naı¨ve T cells
[37–41]. From a representative set of such genes [40] we identified
362 that were also represented on the microarray we used.
Twenty-one percent of these (i.e., 75/362) registered.1.5 fold
changes in expression in Treg cells in the absence of p56Lck
(Figure 6C, Table S4). In 73/75 cases, the changes were in the
direction of diminishing the Treg signature, i.e., in reducing the
difference between Treg cells and conventional naı¨ve T cells. 59 of
the 75 genes (i.e., 79%) were normally upregulated in Treg cells,
and all of these registered a reduction in expression in p56Lck-
deficient T cells. Similarly, 14 genes were normally downregulated
in Treg cells, and these showed upregulation in the absence of
p56Lck. These observations reveal a significant component of the
Treg signature as dependent on p56Lck, and thus point to
sustained/basal TCR signaling as important for maintenance of
this aspect of the Treg phenotype.
Selected microarray data were corroborated by other proce-
dures such as reverse transcriptase PCR analysis of mRNA, and
flow cytometry. Figure 7A shows representative FACS data for
four of the differentially expressed proteins (CCR6, CD103, Ly-
6C, and CD200). Strikingly, CD25+ cells in Lck or Lck/Fyn mice
were markedly enriched for high expression of Ly-6C and low
expression of CD103 (Figure 7B). By contrast, cells that retained
p56Lck expression in the same mice retained a near-normal pattern
of CD103 and Ly-6C expression (Figure 7B, lower panel)
indicating that the effect was intrinsic to cells lacking the kinase
and not a consequence of changes in cytokine levels or other
systemic extrinsic effects.
CCR6 and CD103 expression distinguish Treg cells with an
effector/memory-like phenotype that is induced on activation
[41,42]. Both molecules have been implicated in controlling Treg
cell migration [41,43,44]. Similarly, there is evidence that Ly-6C
expression is of significance for homing of lymphocytes [45]. Given
differential expression of these and other molecules involved in cell
migration, it was of interest to determine whether loss of the TCR
signal due to inactivation of p56Lck expression impacted Treg cell
migration and hence the distribution of Treg cells in the body. To
address this, we examined the representation of cells that had lost
p56Lck (due to inactivation of one copy of the Lck gene by Ox40-cre;
the other allele being congenitally null) in various tissues, and
compared this to the representation of cells in other mice that had
acquired YFP expression (due to Ox40-cre-dependent recombina-
tion of one copy of the ROSA26 YFP reporter allele). Expression of
YFP was expected to be without significant consequence for Treg
cells and should not impact their distribution in the body. Thus the
frequency of YFP+ cells was a useful reference point against which
to look for effects of p56Lck deficiency.
As mentioned earlier, Treg cells lacking p56Lck were more
abundant in the lymph nodes than in the spleen. This was
consistent with the fact that loss of p56Lck was associated with high
expression of CD62L (Figure 5) and a lack of upregulation of
molecules such as CD103, CXCR3, the b1 integrin, Tiam1,
RGS9 and CCR6, which are all of significance for emigration to
tissues or retention in them (Figure 7AB, Table S1) [42,46–48].
The frequency of CD25+ T cells as a fraction of the CD4+
population of T cells was near normal in the lymph nodes, spleens,
livers and lungs of Lck and Lck/Fyn mice, but it was greatly
reduced in their peritoneal cavities (Figure 7C). Much more
strikingly, we noted a large decrease in the representation of
p56Lck-deficient Treg cells (relative to p56Lck-expressing Treg cells)
in the peritoneal cavity in particular, although a less pronounced
effect was evident in all tissues examined (Figure 7D). Collectively,
these data point to a critical role for TCR signaling in the
regulation of Treg cell migration throughout the body and
implicate specific cell surface receptors in this process.
Figure 4. Retention of FoxP3 but abrogation of in vitro suppression in Lck-mutant regulatory cells. A. Real-time PCR analysis of FoxP3
expression in CD25+CD4+ T cells from mice of the indicated genotypes. Expression values were calculated relative to HPRT as an internal standard
using the DDCt method [76], and with normalization to the expression value obtained for the CD252 sample from control mice. B. The graphs show
3H-Thymidine uptake in cultures comprised of CD252 and CD25+ T cells at the stated ratios from mice of the indicated genotypes. Lymph node cells
from mice of the indicated genotypes were flow-sorted then stimulated with soluble anti-CD3 and anti-CD28 in the presence of irradiated wild-type
splenic accessory cells.
doi:10.1371/journal.pone.0006580.g004
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Finally, we noted that CD252CD44hi CD4+ T cells were
present at elevated frequencies in all tissues examined in both Lck
and Lck/Fyn mice (Figure 7C) and the majority of these cells had
undergone Ox40-cre-mediated inactivation of p56Lck (Figure 7D).
Unlike Treg cells (and with the exception of CD44hi CD4+ T cells
in the peritoneal cavity) there was no apparent selection for
retention of p56Lck function in this population. Like Treg cells,
however, proliferating cells were significantly underrepresented
among the CD44hi cells that had undergone recombination
(Figures 4B and C) suggesting that their increased numbers could
not be explained by a shorter cell cycle. The lack of selective
expansion of p56Lck-deficient cells instead suggested that the
increased representation of the CD44hi population was likely to be
a cell-extrinsic consequence of impaired regulatory T cell activity.
Discussion
Inactivation of p56Lck in Treg cells using Ox40-cre and a
conditional null allele of the Lck gene blocks their capacity to signal
through their TCRs and mediate antigen-directed suppression. It
also incurs substantial changes in their basal gene expression
program contributing to their abnormal distribution in the body.
The deficiency blocks proliferation of Treg cells and homeostatic
expansion, but it does not markedly impair their survival. The
results make clear the importance of the TCR signal for Treg cell
function, phenotype and homeostasis.
An induced loss of p56Lck in peripheral T cells has previously
been engineered in mice through complementation of a congenital
deficiency with a tetracycline-regulated Lck transgene [31]. Naı¨ve
p56Lck-deficient T cells in these mice showed long-term survival
but an inability to expand following transfer into lymphopenic
recipients. Survival depended on persistence of p59Fyn function in
the naı¨ve T cells, because in its absence the half-life of the cells was
reduced 4-5-fold, and the cells also gained extreme sensitivity to
blockade of IL-7:IL-7Ra interactions [18]. Basal TCRj phos-
phorylation was substantially reduced in T cells lacking p56Lck, but
it was undetectable when both p56Lck and p59Fyn were missing
[18]. Together with data from other studies [19,21,49–57] these
results indicate that TCR and IL-7 receptor signaling are essential
for the survival of naı¨ve T cells. By contrast, p56Lck deficiency (or
Figure 5. Phenotype of p56Lck-deficient T cells. Flow cytometry data showing expression of the indicated molecules on CD25+ or CD252 lymph
node CD4+ T cells from Lck/Fyn mice. Cells were permeabilized and stained with the 1F6 antibody to discriminate cells that had undergone Ox40-cre-
mediated inactivation of the Lck gene from those that had not (open versus solid curve respectively).
doi:10.1371/journal.pone.0006580.g005
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Figure 6. Gene expression in Lck-mutant regulatory T cells. A. The graphs show normalized log2 ratios of hybridization signals (Lck/Control)
versus average hybridization intensity for all spots on the microarrays. Ratios corresponding to greater than 1.5-fold changes in spot intensity (dotted
lines) are colored black instead of grey, and the numbers of these are indicated at the top and bottom right of the graphs. RNA was purified from
flow-sorted Treg cells (CD4+CD25+) labeled differentially according to its origin (Lck mutant vs. control) and hybridized to microarrays spotted with
70-mer oligos from the MEEBO collection as described in Methods and Materials. B. Bivariate plot of Lck/Control spot ratios in memory versus
regulatory T cells. Numbers of spots with vectors greater than 1.5 (colored black instead of grey) in the indicated parts of the four quadrants are
shown. C. Venn diagram showing overlap between genes that are differentially expressed in control versus Lck memory and/or Treg cells and the
Treg signature gene set identified by Hill et al. [40].
doi:10.1371/journal.pone.0006580.g006
Loss of p56Lck in Treg Cells
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combined p56Lck and p59Fyn deficiency) was found to have no
detectable impact on the survival of memory T cells except in the
presence of IL-7 receptor blockade, in which case CD4+ memory
T cells, but not CD8+ T cells, showed impaired survival [20]. We
show here that Treg cells persist in the absence of both p56Lck and
p59Fyn, and in this respect they are therefore more similar to
memory T cells than to naı¨ve T cells.
Treg cells develop in the absence of IL-7 [58]. They are also
detectable in IL-7Ra-deficient mice [7,59], although in one of two
recent reports they were found to be present in reduced numbers
relative to IL-72/2 mice and were also incapable of in vitro
suppression [59]. These last data raised the possibility that Treg
cell development and homeostasis might depend on both IL-7 and
thymic stromal lymphopoietin (TSLP), both of which deliver
signals through IL-7Ra [60,61]. Whether Treg cells lacking the
TCR signal might show enhanced sensitivity to IL-7Ra and/or
TSLPR blockade has not yet been examined, but the mice
described in this study would now allow for this.
Deletion of Treg cells results in autoimmune disease. This was
initially apparent from studies involving the adoptive transfer of
Treg cell-depleted naı¨ve T cells into irradiated recipients [62], or
from the analysis of mice that received neonatal thymectomies [62–
64]. More recently, it has been made strikingly clear by the rapidly
fatal disease that develops in genetically engineered mice that
feature induced selective depletion of Treg cells [16]. Inactivation of
TCR signaling in Treg cells should be expected to result in disease
because even though Treg cells can develop (Figure 3) they cannot
mediate antigen-directed suppression (Figure 4). Both Lck and Lck/
Fyn mice were, however, free of obvious disease throughout a year-
long observation period and we noted no increase in unexpected
fatalities in the mutant groups relative to controls. Evidence that the
mice were nonetheless undergoing immune responses due to
impaired Treg cell function included mild lymphadenopathy
(Figure 3) and increased frequencies of CD44hiCD252CD4+ T
cells (Figure 7C). These latter T cells lacked expression of activation
markers, and were not actively proliferating, indicating that the
immune responses that created them were not ongoing. The
majority of them had undergone Ox40-cre-mediated inactivation of
p56Lck (data not shown) providing a straightforward explanation for
why they were not acutely activated, and suggesting that they were
the product of clonal expansion that was likely terminated at the
point when OX40 was induced. CD8+CD44hi T cell numbers were
not significantly elevated in the mutant mice, but we nonetheless
detected an increase in the frequency of such cells that had
undergone Ox40-cre-mediated recombination relative to what was
observed in Ox40-cre/YFP mice (data not shown) again consistent
with atypical activation due to impaired Treg cell function.
Although the absence of disease in the mutant mice limited their
usefulness for studying disease suppression by Treg cells, it was an
obvious advantage for studying the Treg cell-intrinsic consequences
of a loss of TCR signaling in the absence of complicating
immunopathology.
Among the most notable consequences of p56Lck inactivation in
Treg cells there was a substantial change in the steady-state pattern
Figure 7. Phenotype and localization of Lck-mutant T cells. A. Flow cytometry validation of selected gene expression differences identified by
microarray analysis. The overlayed histograms show expression of the indicated molecules in CD25+ (top) or CD252 (bottom) T cells that retain (filled
curve) or lack (open curve) expression of functional p56Lck taken from the lymph nodes of Lck mice. B. Expression of Ly-6C and CD103 on cells from
mice of the indicated genotypes (top panel) and in cells that retain or lack expression of p56Lck from Lck/Fyn mice (bottom panel). C. Frequencies of
regulatory (CD25+) or memory (CD252CD44hi) phenotype cells in the indicated locations in Lck, Lck/Fyn or Ox40-cre/YFP mice. Horizontal bars
represent means of the combined Lck and Lck/Fyn data for each location. D. Frequencies of cells with recombined alleles resulting in inactivation of
p56Lck or acquisition of YFP in the same mice and populations studied in C.
doi:10.1371/journal.pone.0006580.g007
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of gene expression. This was immediately evident at the cell surface
(Figures 7 and 9) where the loss of p56Lck function correlated with
dramatic changes in the display of several molecules. Most notably,
compared to control cells, there was upregulation of Ly-6C and
downregulation of CD103, CD200, CCR6, CD5, CD71, GITR,
CD5, CD44 and CTLA4. Consistent with decreased levels of
surface and intracellular molecules that influence migration to
tissues and high levels of surface CD62L, Treg cells that had lost
p56Lck function were under-represented in tissues and the spleen,
but were present in normal frequencies in the lymph nodes.
Whereas gene expression and distribution in the body were
abnormal in p56Lck-deficient Treg cells, we found no obvious
defects in p56Lck-sufficient cells in the same mice. Thus, the changes
observed were intrinsic to Treg cells that had undergone Ox40-cre-
mediated recombination and were not the result of systemic effects.
Under normal conditions, Treg cells can be subdivided into
those that have a ‘naı¨ve-like’ phenotype and those that have an
‘effector/memory’ phenotype [41]. Activation of the former causes
at least some of them to differentiate into the latter and to mobilize
from the lymph nodes to tissues and inflamed sites [41]. The
correlation we have described between changes in gene expression
and redistribution of Treg cells lacking p56Lck function are entirely
consistent with this and indicate that the mobilization of Treg cells
to tissues is a dynamic process that is strongly dependent on
persistent TCR stimulation.
A large fraction of genes showed similar changes in expression
in both Treg cells and conventional T cells following p56Lck
inactivation (Figure 6B). These included genes that are well-
characterized as being responsive to the TCR signal such as those
encoding Egr-1, Egr-2, Egr-3, CD81, CD83, CD200, ALCAM,
RANKL, and Stra13. It also included genes for CD137, CD44,
Tieg1 and NRP1, variation in the expression of which has been
correlated with Treg cell function [65–69]. Genes that were
substantially affected in regulatory but not conventional T cells
included those encoding Myosin-6, Egr-3, PD-1, Ptger2, Galnt14,
Tox, RGS10, LIP1, Ly6f, Txk, and Tec. We noted that among an
independently-derived list of Treg signature genes [40], approx-
imately 20% were differentially expressed in the mutant Treg cells.
While this indicates that a substantial part of the Treg phenotype
(measured at the population level) is dependent on persistent TCR
signaling, it also shows that perhaps the majority of the Treg gene
expression pattern is independent of this. In particular, we found
that although there was a modest reduction in FoxP3 transcript
levels, this decrease was not readily apparent by intracellular
staining for FoxP3 protein. Thus, sustained FoxP3 expression in
Treg cells, like that of many other Treg signature genes, was
relatively insensitive to loss of the TCR signal.
Two of the more striking consequences of p56Lck inactivation in
Treg cells were the upregulation of Ly-6C and myosin-6
expression. The former is a cell surface molecule of unclear
function that has the capacity to influence lymphocyte homing,
while the latter is an actin-based motor with unusual properties
[45,70]. Upregulation of both molecules was initially detected in
the microarray analysis, but was subsequently confirmed by FACS
and real-time RT-PCR respectively. Although the significance of
the upregulation of these genes in the mutant Treg cells remains to
be established, it is possible that monitoring their expression (and
that of other genes identified in this study) could be exploited as a
means to identify cells in nonmutant populations of Treg cells that
are experiencing less TCR signaling than other cells in the same
populations. Such a discrimination might reveal unexpected
relationships between self-responses and Treg cell function.
In almost all of the circumstances we examined, the absence of
p59Fyn had no evident additive effect to the inactivation of p56Lck.
Thus, Treg cells were present at the same average frequency in all
locations in both Lck and Lck/Fyn mice, and their cell surface
phenotype was indistinguishable in both cases. The only difference
we noted between the two types of mice was in the reduced
frequency of memory phenotype CD252 CD4+ T cells in the
lymph nodes of Lck/Fyn compared to Lck mice (Figure 7C). This
decrease was associated with an increased apparent selection
against cells with loss of p56Lck (Figure 7D). p56Lck and p59Fyn have
partially overlapping functions at the CD42CD82 double-
negative stage of development in the thymus [28,29]. They also
both positively regulate Erk activation in naı¨ve CD4+ T cells in
response to TCR ligation [71] and they are at least partially
redundant in regulating naı¨ve T cell survival [18]. Nonetheless,
they phosphorylate distinct substrates and there is evidence that
p59Fyn may be more important for attenuation of T cell signaling
than for its propagation particularly in CD8+ T cells [72]. Thus,
the absence of a more profound consequence of the double
deficiency is not unexpected given the primacy of p56Lck in positive
regulation of TCR signaling.
In conclusion, we have shown here that inactivation of p56Lck –
and thus the TCR signal – incapacitates Treg cells and results in
changes in their gene expression program. Mutant Treg cells
distribute themselves abnormally in the body and although they do
not proliferate, they nonetheless are capable of long-term survival.
The results make clear aspects of the phenotype of Treg cells that
are directly dependent on the TCR signal, while also revealing the
utility of the Ox40-cre allele for conditional mutagenesis in the Treg
lineage.
Materials and Methods
Ethics Statement
All experiments involving animals were performed according to
protocols approved by the UCSF Institutional Animal Care and
Use Committee.
Mice
Ox40-cre mice were generated by gene targeting and contain an
open reading frame encoding the cre recombinase inserted into
exon 3 of the Ox40 gene [25]. The neomycin resistance gene used
for selection of ES cells was removed by Flp recombination in the
germline. The Ox40-cre locus expresses Cre in place of OX40; this
study employed mice that were heterozygous for the cre allele and
demonstrated haploid expression of OX40 from a wild-type Ox40
allele. Heterozygous levels of OX40 are not associated with
immunological defects [30]. ROSA26-loxP-Stop-loxP-YFP mice
were kindly provided by Dr. F. Costantini (Columbia University,
New York, NY). The conditional null allele of the Lck gene has loxP
sites upstream of the translation initiation codon in exon 1 and
downstream of exon 3, and was also generated by gene targeting in
ES cells (Benjamin et al. in preparation). Through use of a cryptic
mRNA splice site, the Cre-recombined form of this allele allows
for translation of a truncated form of p56Lck lacking the amino-
terminal myristylation sequence, the CD4/CD8-interaction do-
main and the epitope recognized by the 1F6 monoclonal antibody.
This truncated form of the protein is generated from thymic
transcripts that derive from the proximal promoter of the Lck gene,
but not from peripheral T cell transcripts deriving from the distal
promoter. Mice homozygous for the Cre-recombined Lck allele
manifest a phenotype that is identical to those of other p56Lck-
deficient mice [73] showing that the truncated thymus-expressed
protein is not functional, and thus the unrecombined allele can be
used as a conditional null allele (Benjamin et al., in preparation).
Mice lacking expression of p59Fyn [74] were provided by Dr.
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Clifford Lowell. TCRbd -deficient mice [75] were purchased from
the Jackson Laboratory (Bar Harbor, ME). All mice were
maintained under specific-pathogen free conditions.
Antibodies, Flow Cytometry, and Cell Sorting
Conjugated antibodies were purchased from BD-Biosciences
(San Diego, CA), Caltag Laboratories (San Francisco, CA), and
eBioscience (San Diego, CA). FACS analysis was performed using
FACSCalibur and LSR II flow cytometers (Becton Dickinson,
Palo Alto, CA). A monoclonal antibody specific for the amino-
terminal region of p56Lck (clone 1F6) originally generated by Dr. J.
Bolen was generously provided by Dr. A. Weiss (UCSF). Single-
cell suspensions were prepared from tissues using 0.45 mm cell
strainers (Falcon; BD Biosciences) and PBS containing BSA (0.3%,
w/v). Percoll fractionation was employed in some cases. Sorting
was performed using a FACSAria (Becton Dickinson, Palo Alto,
CA) to a final cell purity of$95%. For cell cycle analysis, cells were
stained with antibodies specific for cell surface antigens and fixed
for 15 minutes in cytofix/cytoperm solution (BD Biosciences). The
fixed cells were then washed in perm/wash solution (BD
Biosciences) before incubation for at least 10 minutes in perm/
wash solution containing DAPI (14 mM; Sigma) prior to analysis
by flow cytometry.
T Cell Proliferation Assays
CD4+CD252 cells (26104 per well, U-bottom 96-well plate)
and variable numbers of CD4+CD25+ cells were incubated
together for 72 hours in the presence of irradiated (2000 rad)
spleen cells (86104 per well) and anti-CD3 (clone 145–2C11,
2 mg/ml). 3H-thymidine (0.5 mCi/well; Du Pont/NEN) was added
during the last 8 hours of culture. Background counts in wells
containing APCs alone were always,1,000 cpm.
Flow-sorted CD4+CD252 or CD4+CD25+ cells were labeled
with CFSE (2 mM) and washed before intravenous injection into
TCRbd-deficient mice.
Quantitative PCR to detect FoxP3 expression
Total RNA was extracted from 56105 flow-sorted cells using
StrataPrep Total RNA Microprep kits (Stratagene, La Jolla, CA).
To eliminate contaminating genomic DNA, the RNA prepara-
tions were treated with RNase-free DNase I (Invitrogen, Carlsbad,
CA) and reverse-transcribed using Superscript II reverse-tran-
scriptase and oligo(dT)12–18 as primer (Invitrogen). Real-time
PCR was performed using Taqman probes for HPRT and FoxP3
using an MJ Chromo4 machine. Assays were performed in
triplicate, analyzed using the DDCt method [76], and repeated
four times.
Microarray analysis. RNA was prepared from 1–2 million
flow-sorted CD4+CD25+ and CD4+CD252CD44hi cells using the
RNeasy mini kit (Qiagen) with on-column DNAse digestion.
AminoAllyl-modified amplified RNA (aRNA) was prepared from
approximately 1 mg of total RNA using the AminoAllyl Message
Amp II kit (Ambion). 15 mg of this aRNA in 0.05 M sodium
bicarbonate pH 9.0 were then coupled to N-hydroxysuccinimidyl
esters of Cy3 or Cy5 dyes (CyScribe, Amersham Biosciences) for
90 minutes in the dark. The labelled aRNA was neutralized with
100 mM sodium acetate pH 5.5 and purified using the RNA
clean-up kit-25 (Zymo Research). Immediately prior to
hybridization, labelled aRNA samples were fragmented (Ambion
Fragmentation buffer, Ambion) and denatured at 95uC for 10
minutes. Hybridizations to Mouse Exonic Evidence Based
Oligonucleotide (MEEBO) spotted microarrays were performed
at 55uC for 48 hours in Slide Hybridization buffer (Ambion). A
total of 16 arrays were used to analyze regulatory and memory
subsets from eight mice (two arrays per littermate pair, including
dye swaps, were used for each comparison). After hybridization,
the arrays were washed and scanned using an Axon 4000B laser
scanner (Molecular Devices). Image analysis was performed using
Spotreader (Niles Scientific). The ‘print-tip loess’ normalization
[77] was used to correct for within-array dye and spatial effects
and single channel quantile normalization was used to facilitate
comparison between arrays [78]. Functions in the library marray
Norm of the R/Bioconductor package were used to perform these
normalizations [79]. After normalization the Log ratio,
Log2(mutant/control), for each feature on each array was
determined. No background subtraction was performed.
Collections of differentially expressed genes were identified by
selecting those genes that were up- or down-regulated by greater
than 1.5 fold in Treg or memory T cells with inactivated p56Lck,
and for which the B statistic [80] for the microarray data was
greater than zero. A list of Treg cell signature genes [40] was
compared with the entire MEEBO gene list using Gene Name as
the identifier, yielding 362 genes in common. [81]). The
microarray data discussed in this publication are MIAME
compliant and have been deposited in NCBI’s Gene Expression
Omnibus [82] and are accessible through GEO Series accession
number GSE13645 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc = GSE13645).
Supporting Information
Figure S1 Enforced quiescence due to inactivation of p56Lck. A.
Flow cytometry analysis of T cells in the spleens of T cell-deficient
(Tcrbd2/2) recipient mice one month after intravenous transfer of
CD25+ or CD252 T cells. CD4+ T cells (pooled from the lymph
nodes and spleens) from mice of the four indicated genotypes were
flow-sorted, and labeled with CFSE before transfer (16106 cells
per recipient). B. Frequencies of BrdU+ cells (CD25+ or CD252) in
mice at the indicated times after the end of a two-week in vivo
BrdU labeling period. Cells in Lck and Lck/Fyn mice that had or
had not undergone Ox40-cre-mediated inactivation of the Lck gene
were distinguished from one another on the basis of differential
surface expression of CD4 (Figure 5). C. Mitotic status of
regulatory and memory phenotype T cells in mice of the indicated
genotypes. Cells were labeled with DAPI for cell cycle analysis,
and with antibodies against surface molecules, p56Lck and FoxP3.
The histograms show the percentages of cells in S, G2 or M phases
of the cell cycle.
Found at: doi:10.1371/journal.pone.0006580.s001 (0.26 MB TIF)
Figure S2 Regulatory T cells lacking CD4 expression. The
graph at left shows the frequencies of FoxP3+ Treg cells in the
spleens and lymph nodes of mice that differ in whether they
feature Ox40-cre-dependent inactivation of the Cd4 gene. The
graph at right shows the frequencies of Treg cells with an activated
phenotype.
Found at: doi:10.1371/journal.pone.0006580.s002 (0.10 MB TIF)
Table S1 Microarray analysis of gene expression in memory and
regulatory T cells with inactivated p56Lck. A. The spreadsheet
shows the gene expression ratios (Log2(mutant/control)) and B
statistics for individual microarray features from the analysis of
Treg cells. B. The spreadsheet shows the gene expression ratios
(Log2(mutant/control)) and B statistics for individual microarray
features from the analysis of memory T cells.
Found at: doi:10.1371/journal.pone.0006580.s003 (0.18 MB
PDF)
Table S2 Gene ontology term analysis of differentially expressed
genes in memory and regulatory T cells with inactivated p56Lck.
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Genes identified as differentially expressed (.1.5 fold fold-change
and B statistic.0) in p56Lck-deficient cells compared to control
cells were analyzed for enriched gene ontology (GO) annotation
terms relative to the entire mouse genome using the DAVID
Functional Annotation Tools [81] (April 2008 release). p-values for
enrichment were obtained using a modified Fisher Exact test with
adjustment for multiple sampling (Bonferroni). The table shows
biological process GO terms (greater than level 1) associated with
p-values less than 0.05; terms referring to related functions were
grouped then ranked according to fold change (degree of over-
representation of the term in the query list relative to
representation in the mouse genome).
Found at: doi:10.1371/journal.pone.0006580.s004 (0.05 MB
PDF)
Table S3 Gene ontology term analysis of differentially expressed
genes in memory and regulatory T cells with inactivated p56Lck.
Differentially expressed genes (fold change.1.5) were grouped
according to their location in the plot shown in Figure 6B.
Quadrants in the figure were labeled sequentially from upper right
(q1) clockwise to upper left (q4) and the numbers of differentially
expressed genes in each quadrant are shown in brackets at the top
of the table. Enrichment of gene ontology terms was determined as
in Table 1 except that adjustment for multiple sampling was only
used for the analysis of genes in quadrant 3.
Found at: doi:10.1371/journal.pone.0006580.s005 (0.03 MB
PDF)
Table S4 Treg signature genes affected by p56Lck inactivation.
A. 362 genes common to the microarrays used in this study and
those reported in Hill et al. [40]. B. 75 of the genes in Table S4A
that showed.1.5 fold change in expression due to inactivation of
p56Lck. 61 genes that are normally upregulated in Treg cells
compared to conventional T cells are separated from 14 genes (at
the bottom of the list) that are normally downregulated in Treg
cells. 59 of the 61 genes were expressed at reduced levels in the
absence of p56Lck than in its presence (i.e., the loss of p56Lck
diminished the Treg signature); the two genes that showed the
opposite behavior are listed in italics. All 14 genes that are
normally downregulated in Treg cells showed increased expression
in the absence of p56Lck than in its presence (i.e., again, the loss of
p56Lck reduced the Treg signature).
Found at: doi:10.1371/journal.pone.0006580.s006 (0.13 MB
PDF)
Acknowledgments
We thank Ming Hu, Jie Wie and Gavina Benitez for expert technical
assistance, and members of the Killeen laboratory for helpful discussions.
Author Contributions
Conceived and designed the experiments: JKK MK NPK. Performed the
experiments: JKK MK. Analyzed the data: JKK MK YX DE NPK.
Contributed reagents/materials/analysis tools: JB DE DRL. Wrote the
paper: JKK MK NPK.
References
1. Fontenot JD, Rudensky AY (2005) A well adapted regulatory contrivance:
regulatory T cell development and the forkhead family transcription factor
Foxp3. Nat Immunol 6: 331–337.
2. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the
development and function of CD4+CD25+ regulatory T cells. Nat Immunol
4: 330–336.
3. Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for Scurfin
in CD4+CD25+ T regulatory cells. Nat Immunol 4: 337–342.
4. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development
by the transcription factor Foxp3. Science 299: 1057–1061.
5. Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, et al. (2008) Linked T cell
receptor and cytokine signaling govern the development of the regulatory T cell
repertoire. Immunity 28: 112–121.
6. Lio CW, Hsieh CS (2008) A two-step process for thymic regulatory T cell
development. Immunity 28: 100–111.
7. Vang KB, Yang J, Mahmud SA, Burchill MA, Vegoe AL, et al. (2008) IL-2, -7,
and -15, but not thymic stromal lymphopoeitin, redundantly govern
CD4+Foxp3+ regulatory T cell development. J Immunol 181: 3285–3290.
8. Apostolou I, von Boehmer H (2004) In vivo instruction of suppressor
commitment in naive T cells. J Exp Med 199: 1401–1408.
9. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of
peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by
TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875–1886.
10. Cobbold SP, Castejon R, Adams E, Zelenika D, Graca L, et al. (2004) Induction
of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice
tolerized to transplants. J Immunol 172: 6003–6010.
11. Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ (2004) CD25- T
cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.
J Immunol 173: 7259–7268.
12. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, et al.
(2005) Inducing and expanding regulatory T cell populations by foreign antigen.
Nat Immunol 6: 1219–1227.
13. Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, et al. (2005) Oral
tolerance in the absence of naturally occurring Tregs. J Clin Invest 115:
1923–1933.
14. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA (2001) A role for TGF-beta in
the generation and expansion of CD4+CD25+ regulatory T cells from human
peripheral blood. J Immunol 166: 7282–7289.
15. Curotto de Lafaille MA, Kutchukhidze N, Shen S, Ding Y, Yee H, et al. (2008)
Adaptive Foxp3+ regulatory T cell-dependent and -independent control of
allergic inflammation. Immunity 29: 114–126.
16. Kim JM, Rasmussen JP, Rudensky AY (2007) Regulatory T cells prevent
catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8:
191–197.
17. Penhale WJ, Irvine WJ, Inglis JR, Farmer A (1976) Thyroiditis in T cell-depleted
rats: suppression of the autoallergic response by reconstitution with normal
lymphoid cells. Clin Exp Immunol 25: 6–16.
18. Seddon B, Zamoyska R (2002) TCR signals mediated by Src family kinases are
essential for the survival of naive T cells. J Immunol 169: 2997–3005.
19. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B (1997) Differential
requirements for survival and proliferation of CD8 naive or memory T cells.
Science 276: 2057–2062.
20. Seddon B, Tomlinson P, Zamoyska R (2003) Interleukin 7 and T cell receptor
signals regulate homeostasis of CD4 memory cells. Nat Immunol 4: 680–686.
21. Martin B, Becourt C, Bienvenu B, Lucas B (2006) Self-recognition is crucial for
maintaining the peripheral CD4+ T-cell pool in a nonlymphopenic environ-
ment. Blood 108: 270–277.
22. Grandjean I, Duban L, Bonney EA, Corcuff E, Di Santo JP, et al. (2003) Are
major histocompatibility complex molecules involved in the survival of naive
CD4+ T cells? J Exp Med 198: 1089–1102.
23. Dorfman JR, Stefanova I, Yasutomo K, Germain RN (2000) CD4+ T cell
survival is not directly linked to self-MHC-induced TCR signaling. Nat
Immunol 1: 329–335.
24. Siggs OM, Miosge LA, Yates AL, Kucharska EM, Sheahan D, et al. (2007)
Opposing functions of the T cell receptor kinase ZAP-70 in immunity and
tolerance differentially titrate in response to nucleotide substitutions. Immunity
27: 912–926.
25. Klinger M, Kim JK, Chmura SA, Barczak A, Erle DJ, et al. (2009) Thymic
OX40 expression discriminates cells undergoing strong responses to selection
ligands. J Immunol 182: 4581–4589.
26. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, et al. (2001) Cre
reporter strains produced by targeted insertion of EYFP and ECFP into the
ROSA26 locus. BMC Dev Biol 1: 4.
27. Straus DB, Weiss A (1992) Genetic evidence for the involvement of the lck
tyrosine kinase in signal transduction through the T cell antigen receptor. Cell
70: 585–593.
28. Groves T, Smiley P, Cooke MP, Forbush K, Perlmutter RM, et al. (1996) Fyn
can partially substitute for Lck in T lymphocyte development. Immunity 5:
417–428.
29. van Oers NS, Lowin-Kropf B, Finlay D, Connolly K, Weiss A (1996) alpha beta
T cell development is abolished in mice lacking both Lck and Fyn protein
tyrosine kinases. Immunity 5: 429–436.
30. Pippig SD, Pena-Rossi C, Long J, Godfrey WR, Fowell DJ, et al. (1999) Robust
B cell immunity but impaired T cell proliferation in the absence of CD134
(OX40). J Immunol 163: 6520–6529.
31. Seddon B, Legname G, Tomlinson P, Zamoyska R (2000) Long-term survival
but impaired homeostatic proliferation of Naive T cells in the absence of p56lck.
Science 290: 127–131.
Loss of p56Lck in Treg Cells
PLoS ONE | www.plosone.org 12 August 2009 | Volume 4 | Issue 8 | e6580
32. Killeen N, Davis CB, Chu K, Crooks ME, Sawada S, et al. (1993) CD4 function
in thymocyte differentiation and T cell activation. Philos Trans R Soc
Lond B Biol Sci 342: 25–34.
33. Wang Q, Strong J, Killeen N (2001) Homeostatic competition among T cells
revealed by conditional inactivation of the mouse Cd4 gene. J Exp Med 194:
1721–1730.
34. Roose JP, Diehn M, Tomlinson MG, Lin J, Alizadeh AA, et al. (2003) T cell
receptor-independent basal signaling via Erk and Abl kinases suppresses RAG
gene expression. PLoS Biol 1: E53.
35. Pelchen-Matthews A, Boulet I, Littman DR, Fagard R, Marsh M (1992) The
protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of
CD4 into coated pits. J Cell Biol 117: 279–290.
36. Pelchen-Matthews A, da Silva RP, Bijlmakers MJ, Signoret N, Gordon S, et al.
(1998) Lack of p56lck expression correlates with CD4 endocytosis in primary
lymphoid and myeloid cells. Eur J Immunol 28: 3639–3647.
37. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005)
Regulatory T cell lineage specification by the forkhead transcription factor
foxp3. Immunity 22: 329–341.
38. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, et al. (2007)
Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445:
771–775.
39. Herman AE, Freeman GJ, Mathis D, Benoist C (2004) CD4+CD25+ T
regulatory cells dependent on ICOS promote regulation of effector cells in the
prediabetic lesion. J Exp Med 199: 1479–1489.
40. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, et al. (2007) Foxp3
transcription-factor-dependent and -independent regulation of the regulatory T
cell transcriptional signature. Immunity 27: 786–800.
41. Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, et al. (2004)
Developmental stage, phenotype, and migration distinguish naive- and effector/
memory-like CD4+ regulatory T cells. J Exp Med 199: 303–313.
42. Kleinewietfeld M, Puentes F, Borsellino G, Battistini L, Rotzschke O, et al.
(2005) CCR6 expression defines regulatory effector/memory-like cells within the
CD25(+)CD4+ T-cell subset. Blood 105: 2877–2886.
43. Siegmund K, Feuerer M, Siewert C, Ghani S, Haubold U, et al. (2005)
Migration matters: regulatory T-cell compartmentalization determines suppres-
sive activity in vivo. Blood 106: 3097–3104.
44. Varona R, Cadenas V, Lozano M, Moreno-Ortiz MC, Kremer L, et al. (2006)
CCR6 regulates the function of alloreactive and regulatory CD4+ T cells during
acute graft-versus-host disease. Leuk Lymphoma 47: 1469–1476.
45. Hanninen A, Jaakkola I, Salmi M, Simell O, Jalkanen S (1997) Ly-6C regulates
endothelial adhesion and homing of CD8(+) T cells by activating integrin-
dependent adhesion pathways. Proc Natl Acad Sci U S A 94: 6898–6903.
46. Agenes F, Bosco N, Mascarell L, Fritah S, Ceredig R (2005) Differential
expression of regulator of G-protein signalling transcripts and in vivo migration
of CD4+ naive and regulatory T cells. Immunology 115: 179–188.
47. Gerard A, Mertens AE, van der Kammen RA, Collard JG (2007) The Par
polarity complex regulates Rap1- and chemokine-induced T cell polarization.
J Cell Biol 176: 863–875.
48. Muller M, Carter SL, Hofer MJ, Manders P, Getts DR, et al. (2007) CXCR3
signaling reduces the severity of experimental autoimmune encephalomyelitis by
controlling the parenchymal distribution of effector and regulatory T cells in the
central nervous system. J Immunol 179: 2774–2786.
49. Brocker T (1997) Survival of mature CD4 T lymphocytes is dependent on major
histocompatibility complex class II-expressing dendritic cells. J Exp Med 186:
1223–1232.
50. Kirberg J, Berns A, von Boehmer H (1997) Peripheral T cell survival requires
continual ligation of the T cell receptor to major histocompatibility complex-
encoded molecules. J Exp Med 186: 1269–1275.
51. Rooke R, Waltzinger C, Benoist C, Mathis D (1997) Targeted complementation
of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses.
Immunity 7: 123–134.
52. Viret C, Wong FS, Janeway CA Jr (1999) Designing and maintaining the mature
TCR repertoire: the continuum of self-peptide:self-MHC complex recognition.
Immunity 10: 559–568.
53. Witherden D, van Oers N, Waltzinger C, Weiss A, Benoist C, et al. (2000)
Tetracycline-controllable selection of CD4(+) T cells: half-life and survival
signals in the absence of major histocompatibility complex class II molecules.
J Exp Med 191: 355–364.
54. Polic B, Kunkel D, Scheffold A, Rajewsky K (2001) How alpha beta T cells deal
with induced TCR alpha ablation. Proc Natl Acad Sci U S A 98: 8744–8749.
55. Swain SL, Hu H, Huston G (1999) Class II-independent generation of CD4
memory T cells from effectors. Science 286: 1381–1383.
56. Schluns KS, Kieper WC, Jameson SC, Lefrancois L (2000) Interleukin-7
mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat
Immunol 1: 426–432.
57. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, et al. (2001) IL-7 is critical for
homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A
98: 8732–8737.
58. Peffault de Latour R, Dujardin HC, Mishellany F, Burlen-Defranoux O, Zuber J,
et al. (2006) Ontogeny, function, and peripheral homeostasis of regulatory T
cells in the absence of interleukin-7. Blood 108: 2300–2306.
59. Mazzucchelli R, Hixon JA, Spolski R, Chen X, Li WQ, et al. (2008)
Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or
TSLP. Blood 112: 3283–3292.
60. Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, et al. (2000) Cloning of a
receptor subunit required for signaling by thymic stromal lymphopoietin. Nat
Immunol 1: 59–64.
61. Park LS, Martin U, Garka K, Gliniak B, Di Santo JP, et al. (2000) Cloning of the
murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a
functional heteromeric complex requires interleukin 7 receptor. J Exp Med
192: 659–670.
62. Powrie F, Mason D (1990) OX-22high CD4+ T cells induce wasting disease with
multiple organ pathology: prevention by the OX-22low subset. J Exp Med 172:
1701–1708.
63. Sakaguchi S, Takahashi T, Nishizuka Y (1982) Study on cellular events in post-
thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in
normal female mice for the prevention of oophoritis. J Exp Med 156:
1577–1586.
64. Sakaguchi S, Takahashi T, Nishizuka Y (1982) Study on cellular events in
postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1
effector cells for oocytes damage after adoptive transfer. J Exp Med 156:
1565–1576.
65. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, et al. (2004)
Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 34:
623–630.
66. Elpek KG, Yolcu ES, Franke DD, Lacelle C, Schabowsky RH, et al. (2007) Ex
vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy
between IL-2 and 4-1BB signaling. J Immunol 179: 7295–7304.
67. Firan M, Dhillon S, Estess P, Siegelman MH (2006) Suppressor activity and
potency among regulatory T cells is discriminated by functionally active CD44.
Blood 107: 619–627.
68. Glinka Y, Prud’homme GJ (2008) Neuropilin-1 is a receptor for transforming
growth factor beta-1, activates its latent form, and promotes regulatory T cell
activity. J Leukoc Biol 84: 302–310.
69. Venuprasad K, Huang H, Harada Y, Elly C, Subramaniam M, et al. (2008) The
E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and
airway inflammation by enhancing the function of transcription factor TIEG1.
Nat Immunol 9: 245–253.
70. Sweeney HL, Houdusse A (2007) What can myosin VI do in cells? Curr Opin
Cell Biol 19: 57–66.
71. Lovatt M, Filby A, Parravicini V, Werlen G, Palmer E, et al. (2006) Lck
regulates the threshold of activation in primary T cells, while both Lck and Fyn
contribute to the magnitude of the extracellular signal-related kinase response.
Mol Cell Biol 26: 8655–8665.
72. Filby A, Seddon B, Kleczkowska J, Salmond R, Tomlinson P, et al. (2007) Fyn
regulates the duration of TCR engagement needed for commitment to effector
function. J Immunol 179: 4635–4644.
73. Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Narendran A, et al.
(1992) Profound block in thymocyte development in mice lacking p56lck. Nature
357: 161–164.
74. Stein PL, Lee HM, Rich S, Soriano P (1992) pp59fyn mutant mice display
differential signaling in thymocytes and peripheral T cells. Cell 70: 741–750.
75. Mombaerts P, Arnoldi J, Russ F, Tonegawa S, Kaufmann SH (1993) Different
roles of alpha beta and gamma delta T cells in immunity against an intracellular
bacterial pathogen. Nature 365: 53–56.
76. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:
402–408.
77. Smyth GK, Speed T (2003) Normalization of cDNA microarray data. Methods
31: 265–273.
78. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of
normalization methods for high density oligonucleotide array data based on
variance and bias. Bioinformatics 19: 185–193.
79. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004)
Bioconductor: open software development for computational biology and
bioinformatics. Genome Biol 5: R80.
80. Lonnstedt I, Speed TP (2002) Replicated microarray data. Stat Sinica 2: 31–46.
81. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID:
Database for Annotation, Visualization, and Integrated Discovery. Genome Biol
4: P3.
82. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI
gene expression and hybridization array data repository. Nucleic Acids Res 30:
207–210.
Loss of p56Lck in Treg Cells
PLoS ONE | www.plosone.org 13 August 2009 | Volume 4 | Issue 8 | e6580
